| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |